Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 26;12(5):e0177745.
doi: 10.1371/journal.pone.0177745. eCollection 2017.

The association between cholecystectomy and colorectal neoplasm in inflammatory bowel diseases: A population-based cohort study

Affiliations

The association between cholecystectomy and colorectal neoplasm in inflammatory bowel diseases: A population-based cohort study

Yen-Chun Peng et al. PLoS One. .

Abstract

Background & aims: Inflammatory bowel diseases (IBD) and cholecystectomy are associated with the risk of colorectal cancer (CRC). Our aim was to determine the association between cholecystectomy and the CRC risk in IBD.

Methods: We first obtained the Taiwan National Health Insurance Research Database (NHRID), which contains information on approximately 24.7 million insured individuals. A cohort study was conducted using the data from the NHIRD, and included cohort patients with IBD who had experienced a cholecystectomy between the years 1998 and 2010. The non-cholecystectomy cohort comprised the remaining IBD patients who had not undergone a cholecystectomy. Multivariate Cox proportional hazard regression analysis was used to determine the effects cholecystectomy have on the risks of developing CRC, as shown by Hazard Ratios (HRs) with 95% confidence intervals (CIs).

Results: The incidence rate of CRC among IBD patients who had undergone a cholecystectomy (n = 525) was 1.75 per 1,000 person-years, compared to 1.41 per 1,000 person-years among IBD patients who had not had a cholecystectomy (n = 525). The adjusted HRs for CRC was found to be 0.76 (95% CI 0.25-2.32) for IBD patients having received a cholecystectomy, after adjusting for age, gender, and comorbidities. By type of IBD, neither ulcerative colitis nor Crohn's diseases are associated with CRC after a cholecystectomy adjusted HR (2.78 [95% CI 0.54-14.3]) and (0.13 [95% CI 0.01-1.49]).

Conclusion: In Taiwan, cholecystectomies are not associated with a risk of CRC in patients with IBD.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Kaplan-Meir method determined cumulative incidence of colorectal cancer compared between cholecystectomy cohort and non-cholecystectomy cohort.

References

    1. Sebastian S, Hernandez V, Myrelid P, Kariv R, Tsianos E, Toruner M, et al. Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I). Journal of Crohn's & colitis. 2014;8(1):5–18. - PubMed
    1. Baars JE, Looman CW, Steyerberg EW, Beukers R, Tan AC, Weusten BL, et al. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study. The American journal of gastroenterology. 2011;106(2):319–28. doi: 10.1038/ajg.2010.428 - DOI - PubMed
    1. Schernhammer ES, Leitzmann MF, Michaud DS, Speizer FE, Giovannucci E, Colditz GA, et al. Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas. British journal of cancer. 2003;88(1):79–83. doi: 10.1038/sj.bjc.6600661 - DOI - PMC - PubMed
    1. Shao T, Yang YX. Cholecystectomy and the risk of colorectal cancer. The American journal of gastroenterology. 2005;100(8):1813–20. doi: 10.1111/j.1572-0241.2005.41610.x - DOI - PubMed
    1. Vinikoor LC, Robertson DJ, Baron JA, Silverman WB, Sandler RS. Cholecystectomy and the risk of recurrent colorectal adenomas. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2007;16(7):1523–5. - PubMed